Skip to main content
GutCited

Beschreibung

Relative abundance of key bacterial taxa is compared between synbiotic and placebo groups, highlighting Lactobacillus and Bifidobacterium dynamics.

Figure 28

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 28: Relative abundance of key bacterial taxa is compared between synbiotic and placebo groups, highlighting Lactobacillus and Bifidobacterium dynamics.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure>
  <img src="" alt="Relative abundance of key bacterial taxa is compared between synbiotic and placebo groups, highlighting Lactobacillus and Bifidobacterium dynamics." />
  <figcaption>Figure 28. Relative abundance of key bacterial taxa is compared between synbiotic and placebo groups, highlighting Lactobacillus and Bifidobacterium dynamics.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Verwandte Evidenz

B
Bifidobacterium longum für Irritable Bowel Syndrome (IBS)

Bewertung B · 4 Studien

 B
Galactooligosaccharides (GOS) für Irritable Bowel Syndrome (IBS)

Bewertung B · 3 Studien

 B
Lactobacillus acidophilus für Irritable Bowel Syndrome (IBS)

Bewertung B · 3 Studien

 D
Fructooligosaccharides (FOS) für Irritable Bowel Syndrome (IBS)

Bewertung D · 2 Studien